Antihypertensive AgentsHypertensionBlood PressureHydrochlorothiazideDiureticsAtenololAngiotensin-Converting Enzyme InhibitorsAmlodipineCalcium Channel BlockersHydralazineMethyldopaSodium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsMinoxidilBendroflumethiazideRats, Inbred SHRDoxazosinAngiotensin II Type 1 Receptor BlockersCaptoprilTetrazolesLisinoprilNordefrinGlutamyl AminopeptidaseDihydropyridinesAngiotensin Receptor AntagonistsDrug Therapy, CombinationTreatment OutcomeClonidineEnalaprilIndapamideLabetalolBlood Pressure Monitoring, AmbulatoryGuanfacineDouble-Blind MethodPerindoprilBenzimidazolesHypertension, RenalBlood Pressure DeterminationRenin-Angiotensin SystemNifedipineImidazoline ReceptorsHeart RatePropanolaminesLosartanDiltiazemReninPrazosinRats, Inbred WKYDose-Response Relationship, DrugPatient ComplianceChlorthalidoneClinical Trials as TopicAdrenergic alpha-AntagonistsFumaratesBiphenyl CompoundsSystoleTime FactorsImidazolesDrug CombinationsMedication AdherencePropranololValineKidney Failure, ChronicDesoxycorticosteroneHypertension, RenovascularKidneyFollow-Up StudiesRisk FactorsPhenylacetatesAdministration, OralProspective StudiesRandomized Controlled Trials as TopicBenzopyransDiabetic NephropathiesCardiovascular DiseasesHemodynamicsDelayed-Action PreparationsProteinuriaTrichlormethiazideDiabetes Mellitus, Type 2ArteriesCardiovascular SystemDiabetes ComplicationsAmidesThiazidesKidney DiseasesVasodilator AgentsAortaCreatinineRetrospective StudiesBenzothiadiazinesRisk AssessmentSympathetic Nervous SystemStrokeHypertrophy, Left VentricularDisease Models, AnimalFelodipineRamiprilCilazaprilNicardipine